Terminated NA INTERVENTIONAL 1-arm NCT00762138

The AutoloGel™ Post-Market Surveillance (TAPS) Program (TAPS)

Sponsor: CTI Clinical Trial and Consulting Services

Conditions Diabetic Foot Ulcers Leg Ulcers Pressure Ulcers Wounds

Updated 5 times since 2017 Last updated: Feb 25, 2014 Started: Sep 30, 2008 Primary completion: May 31, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Discontinued due to favorable results

Other terminated trials from CTI Clinical Trial and Consulting Services

See all terminations from CTI Clinical Trial and Consulting Services

Other Diabetic Foot Ulcers trials with similar outcome

Browse all Diabetic Foot Ulcers trials

This NA trial investigates Diabetic Foot Ulcers and Leg Ulcers and is currently terminated or withdrawn. CTI Clinical Trial and Consulting Services leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CTI Clinical Trial and Consulting Services
Cytomedix

Data source: Cytomedix

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Augusta, United States
• El Paso, United States